Refractory chronic cough (RCC) has a significant impact on the lives of afflicted patients. Diagnosis of RCC can be challenging, as it requires thorough evaluation for and treatment of any possible underlying causes. Fortunately for patients determined to have RCC, the pharmacologic landscape is evolving, with a variety of novel therapies under development. Join us for an engaging live symposium at the ATS 2026 International Conference where you will hear leading RCC experts provide valuable insights related to diagnosis, underlying pathophysiology, and the latest treatment advances on the horizon. The discussion will feature real-world patient data from a national survey to shed light on lived experiences with RCC and video-based patient testimonials which will support an interactive gamified differential diagnosis activity. Additionally, this session will feature a 2D animation that depicts key components of the driving factors underlying RCC as well as polling and live Q&A for direct engagement with expert faculty. Don't miss this opportunity to enhance your clinical expertise and engage with leading experts to improve the care of your patients with RCC!